Return to Listing

1 result(s) for CDX-1127

PI Name Protocol # Title
Matthew Taylor IRB00009622 A Phase 1, Open-Label, Dose-Escalation, Safety and Pharmacokinetic Study of CDX-1127 in Patients with Selected Refractory or Relapsed Hematologic Malignancies or Solid Tumors

You may also qualify for Phase 1 Program trials.

For more information:
Call: 503-494-1080